Vaccines in the post-COVID-19 world: Distrust amid promising developmentsByDon TracyNovember 11th 2024At the Financial Times Global Pharma and Biotech Summit 2024, a panel discussed the potential of mRNA technology in developing cancer vaccines amid distrust from the public.